Since TILs at tumor sites in NPC patients appear to be in an activated state [25] and may be involved in inducing IDO expression, we mimicked the interplay between activated lymphocytes and tumor cells by culturing CNE2 cells in CM from IL-2 stimulated PBLs, and analyzed the amount of IDO expression by western blot analysis. The gene discussed is IDO1; the disease is neoplasm.